Literature DB >> 2719465

Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.

M Venditti1, C Santini, P Serra, A Micozzi, G Gentile, P Martino.   

Abstract

We evaluated the in vitro antibiotic susceptibilities of 31 coagulase-negative Staphylococcus isolates causing septicemia in neutropenic patients undergoing norfloxacin prophylaxis. All the strains but one were resistant to 1 microgram of norfloxacin per ml. At the same concentration, ciprofloxacin, ofloxacin, imipenem, and pefloxacin were inhibitory for 19 (61%), 19 (61%), 18 (58%), and 14 (45%) of the evaluated strains, respectively. Imipenem had an MBC/MIC ratio of greater than or equal to 32 against 19 (61%) of the evaluated isolates, and resistant subpopulations were detected at 5 micrograms/ml in 16 of 17 oxacillin-resistant strains and in 3 of 14 oxacillin-susceptible or -tolerant strains. Resistance to gentamicin was seen with increased frequency among slime-producing strains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719465      PMCID: PMC171458          DOI: 10.1128/AAC.33.2.209

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.

Authors:  D S Davenport; R M Massanari; M A Pfaller; M J Bale; S A Streed; W J Hierholzer
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

2.  Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome.

Authors:  J J Younger; G D Christensen; D L Bartley; J C Simmons; F F Barrett
Journal:  J Infect Dis       Date:  1987-10       Impact factor: 5.226

3.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

4.  Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  C Thornsberry; L K McDougal
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

5.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin.

Authors:  J L Witte; F L Sapico; H N Canawati
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

Authors:  A W Dekker; M Rozenberg-Arska; J Verhoef
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

8.  Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Authors:  M Rozenberg-Arska; A W Dekker; J Verhoef
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

9.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more
  9 in total

1.  Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.

Authors:  W Kern; E Kurrle
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

2.  Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Authors:  W V Kern; E Andriof; M Oethinger; P Kern; J Hacker; R Marre
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

3.  Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.

Authors:  C C Patrick; M R Plaunt; S V Hetherington; S M May
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Species identification and detection of oxacillin resistance in coagulase-negative Staphylococcus blood isolates from neutropenic patients.

Authors:  M Venditti; S Santilli; P Petasecca Donati; A Micozzi; G Gentile; P Martino
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

5.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.

Authors:  A Micozzi; M Nucci; M Venditti; G Gentile; C Girmenia; G Meloni; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

Review 7.  Infections due to antibiotic-resistant gram-positive cocci.

Authors:  G M Caputo; M Singer; S White; M R Weitekamp
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

8.  Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  H Ludlam; L Johnston; P Hopkins
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

9.  Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients.

Authors:  M Giuliano; A Pantosti; G Gentile; M Venditti; W Arcese; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.